CompletedPhase 4NCT03395223

MEthylene Blue In Patients With Acquired Methemoglobinemia

Studying Acquired methemoglobinemia

Last synced from ClinicalTrials.gov May 1, 2026

ℹ

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.

Report missing data

Key facts

Sponsor: Provepharm SAS
Principal Investigator: Bruno Megarbane
Hôpital Lariboisière
Intervention: Methylene Blue(drug)
Enrollment: 7 enrolled
Eligibility: All sexes
Timeline: 2018 – 2020

Study locations (1)

Hôpital Lariboisière, Paris, France

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT03395223 on ClinicalTrials.gov

← Back to all trials